Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21430051rdf:typepubmed:Citationlld:pubmed
pubmed-article:21430051lifeskim:mentionsumls-concept:C0682451lld:lifeskim
pubmed-article:21430051lifeskim:mentionsumls-concept:C0230595lld:lifeskim
pubmed-article:21430051lifeskim:mentionsumls-concept:C1414387lld:lifeskim
pubmed-article:21430051lifeskim:mentionsumls-concept:C0146495lld:lifeskim
pubmed-article:21430051pubmed:issue11lld:pubmed
pubmed-article:21430051pubmed:dateCreated2011-5-9lld:pubmed
pubmed-article:21430051pubmed:abstractTextUs3, a serine/threonine kinase encoded by all alphaherpesviruses, plays diverse roles during virus infection, including preventing virus-induced apoptosis, facilitating nuclear egress of capsids, stimulating mRNA translation and promoting cell-to-cell spread of virus infection. Given this diversity, the full spectrum of Us3 function may not yet be recognized. We noted, in transiently transfected cells, that herpes simplex virus type 2 (HSV-2) Us3 disrupted promyelocytic leukemia protein nuclear bodies (PML-NBs). However, PML-NB disruption was not observed in cells expressing catalytically inactive HSV-2 Us3. Analysis of PML-NBs in Vero cells transfected with pseudorabies virus (PRV) Us3 and those in Vero cells infected with Us3-null or -repaired PRV strains indicated that PRV Us3 expression also leads to the disruption of PML-NBs. While loss of PML-NBs in response to Us3 expression was prevented by the proteasome inhibitor MG132, Us3-mediated degradation of PML was not observed in infected cells or in transfected cells expressing enhanced green fluorescent protein (EGFP)-tagged PML isoform IV. These findings demonstrate that Us3 orthologues derived from distantly related alphaherpesviruses cause a disruption of PML-NBs in a kinase- and proteasome-dependent manner but, unlike the alphaherpesvirus ICP0 orthologues, do not target PML for degradation.lld:pubmed
pubmed-article:21430051pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:languageenglld:pubmed
pubmed-article:21430051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:citationSubsetIMlld:pubmed
pubmed-article:21430051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21430051pubmed:statusMEDLINElld:pubmed
pubmed-article:21430051pubmed:monthJunlld:pubmed
pubmed-article:21430051pubmed:issn1098-5514lld:pubmed
pubmed-article:21430051pubmed:authorpubmed-author:BanfieldBruce...lld:pubmed
pubmed-article:21430051pubmed:authorpubmed-author:FinnenRenée...lld:pubmed
pubmed-article:21430051pubmed:authorpubmed-author:JungMasanyMlld:pubmed
pubmed-article:21430051pubmed:authorpubmed-author:NeronCasey...lld:pubmed
pubmed-article:21430051pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21430051pubmed:volume85lld:pubmed
pubmed-article:21430051pubmed:ownerNLMlld:pubmed
pubmed-article:21430051pubmed:authorsCompleteYlld:pubmed
pubmed-article:21430051pubmed:pagination5301-11lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:meshHeadingpubmed-meshheading:21430051...lld:pubmed
pubmed-article:21430051pubmed:year2011lld:pubmed
pubmed-article:21430051pubmed:articleTitleThe alphaherpesvirus serine/threonine kinase us3 disrupts promyelocytic leukemia protein nuclear bodies.lld:pubmed
pubmed-article:21430051pubmed:affiliationDepartment of Microbiology and Immunology, Queen's University, Ontario, Canada.lld:pubmed
pubmed-article:21430051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21430051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21430051pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:5371entrezgene:pubmedpubmed-article:21430051lld:entrezgene
entrez-gene:1487355entrezgene:pubmedpubmed-article:21430051lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21430051lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21430051lld:entrezgene